Learn More
In the present study, a highly stable luteinizing-hormone-releasing hormone (LHRH)-conjugated PEGylated poly(lactic-co-glycolic acid) (PLGA) nanoparticles were developed for the successful treatment of prostate cancers. We have demonstrated that a unique combination of targeted drug delivery and controlled drug release is effective against prostate cancer(More)
A novel two-dimensional (2D) nanomaterial, namely sulfonated graphenal polymer (SGP), is used to tune the hydrothermal growth of Co3O4 nanoparticles. SGP provides abundant nucleation sites to grow Co3O4 nanoparticles and effectively reduces the particle size and dimension. As a result, with considering the improved size uniformity of Co3O4 and the tight(More)
  • 1